Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Condition:   Clear Cell Renal Cell Carcinoma Intervention:   Drug: ARO-HIF2 Sponsor:   Arrowhead Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials